ACP
Acuta Capital Partners’s Xenon Pharmaceuticals XENE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-272,500
| Closed | -$9.84M | – | 47 |
|
|
2022
Q3 | $9.84M | Hold |
272,500
| – | – | 4.24% | 6 |
|
|
2022
Q2 | $8.29M | Buy |
272,500
+47,500
| +21% | +$1.44M | 4.62% | 6 |
|
|
2022
Q1 | $6.88M | Hold |
225,000
| – | – | 3.21% | 10 |
|
|
2021
Q4 | $7.03M | Sell |
225,000
-192,409
| -46% | -$6.01M | 2.95% | 11 |
|
|
2021
Q3 | $6.38M | Hold |
417,409
| – | – | 2.25% | 14 |
|
|
2021
Q2 | $7.77M | Buy |
417,409
+4,909
| +1% | +$91.4K | 3.11% | 8 |
|
|
2021
Q1 | $7.38M | Buy |
412,500
+332,500
| +416% | +$5.95M | 2.66% | 14 |
|
|
2020
Q4 | $1.23M | Sell |
80,000
-220,000
| -73% | -$3.38M | 0.33% | 40 |
|
|
2020
Q3 | $3.32M | Sell |
300,000
-217,500
| -42% | -$2.41M | 0.9% | 33 |
|
|
2020
Q2 | $6.49M | Sell |
517,500
-111,000
| -18% | -$1.39M | 1.87% | 23 |
|
|
2020
Q1 | $7.13M | Sell |
628,500
-289,000
| -31% | -$3.28M | 3.45% | 10 |
|
|
2019
Q4 | $12M | Buy |
917,500
+215,000
| +31% | +$2.82M | 2.98% | 10 |
|
|
2019
Q3 | $6.33M | Buy |
702,500
+1,000
| +0.1% | +$9.01K | 4.57% | 7 |
|
|
2019
Q2 | $6.92M | Buy |
701,500
+149,000
| +27% | +$1.47M | 2.46% | 15 |
|
|
2019
Q1 | $5.61M | Buy |
552,500
+15,000
| +3% | +$152K | 2.67% | 15 |
|
|
2018
Q4 | $3.39M | Buy |
537,500
+55,000
| +11% | +$347K | 2.59% | 12 |
|
|
2018
Q3 | $6.37M | Buy |
482,500
+32,500
| +7% | +$429K | 2.27% | 12 |
|
|
2018
Q2 | $4.14M | Buy |
+450,000
| New | +$4.14M | 0.74% | 23 |
|